Long-term outcome after endoscopic submucosal dissection for early gastric cancer: Focusing on a group beyond the expanded indication
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Myung Soo | - |
dc.contributor.author | Hong, Su Jin | - |
dc.contributor.author | Kim, Dae Yong | - |
dc.contributor.author | Han, Jae Pil | - |
dc.contributor.author | Choi, Moon Han | - |
dc.contributor.author | Kim, Hee Kyung | - |
dc.contributor.author | Ko, Bong Min | - |
dc.contributor.author | Lee, Moon Sung | - |
dc.date.accessioned | 2021-08-11T20:46:22Z | - |
dc.date.available | 2021-08-11T20:46:22Z | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 1751-2972 | - |
dc.identifier.issn | 1751-2980 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10982 | - |
dc.description.abstract | ObjectiveTo determine the long-term outcome after endoscopic submucosal dissection (ESD) in patients with early gastric cancer (EGC) according to the pathological extent. MethodsESD were performed in 280 patients with 309 EGC. The tumors were classified by pathological severity based on absolute indication (AI), expanded indication (EI) or beyond expanded indication (BEI). The therapeutic outcomes among the three groups were analyzed. ResultsThe complete resection rates of EGC were 96.4%, 78.7% and 41.2% in the AI-EGC, EI-EGC and BEI-EGC groups, respectively (P=0.000). En bloc resection rates were 97.6%, 87.4% and 86.3% in the AI-EGC, EI-EGC and BEI-EGC groups, respectively (P=0.023). The 5-year tumor recurrence rates were 1.8%, 1.5% and 15.4% in the AI-EGC, EI-EGC and BEI-EGC groups, respectively (P=0.000). The 5-year disease-specific survival rates were 100%, 100% and 97.4% in the AI-EGC, EI-GEC and BEI-EGC groups, respectively (P=0.088). The 5-year disease-free survival rates were 98.2%, 98.5% and 84.6% in the AI-EGC, EI-EGC and BEI-EGC groups, respectively (P=0.000). ConclusionsESD was effective and safe in treating AI-EGC and EI-EGC, but there was a comparatively high rate of recurrence after ESD in the BEI-EGC group. However, long-term outcomes of patients with BEI-EGC that did not receive additional surgery were better than those with an natural course of EGC. Thus, ESD may be considered for specific BEI-EGC patients at high risk for surgery. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Blackwell Pub. Asia | - |
dc.title | Long-term outcome after endoscopic submucosal dissection for early gastric cancer: Focusing on a group beyond the expanded indication | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/1751-2980.12208 | - |
dc.identifier.scopusid | 2-s2.0-84925857263 | - |
dc.identifier.wosid | 000349123900002 | - |
dc.identifier.bibliographicCitation | Journal of Digestive Diseases, v.16, no.1, pp 7 - 13 | - |
dc.citation.title | Journal of Digestive Diseases | - |
dc.citation.volume | 16 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 7 | - |
dc.citation.endPage | 13 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | MUCOSAL RESECTION | - |
dc.subject.keywordAuthor | early gastric cancer | - |
dc.subject.keywordAuthor | endoscopic submucosal dissection | - |
dc.subject.keywordAuthor | expanded indication | - |
dc.subject.keywordAuthor | long-term | - |
dc.subject.keywordAuthor | outcome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.